Imago Bio Sciences
Biotechnology, South San Francisco CA Us, Redwood City, California, 94080, United States, 11-50 Employees
Phone Number: 41********
Who is IMAGO BIOSCIENCES
Our scientific efforts are aimed at developing drugs that improve the management of proliferative diseases of the bone marrow. Our clinical focus is on acute myeloid leukemia, myelodyspla...
Read More
- Headquarters: South San Francisco CA 94080 Us, Redwood City, California, 94080, United States
- Date Founded: 2012
- Employees: 11-50
- Revenue: $5 Million to $10 Million
- Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2836 | NAICS Code: 541714 | Show More
Does something look wrong? Fix it. | View contact records from IMAGO BIOSCIENCES
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Imago BioSciences
Answer: Imago BioSciences's headquarters are located at South San Francisco CA Us, Redwood City, California, 94080, United States
Answer: Imago BioSciences's phone number is 41********
Answer: Imago BioSciences's official website is https://imagobio.com
Answer: Imago BioSciences's revenue is $5 Million to $10 Million
Answer: Imago BioSciences's SIC: 2836
Answer: Imago BioSciences's NAICS: 541714
Answer: Imago BioSciences has 11-50 employees
Answer: Imago BioSciences is in Biotechnology
Answer: Imago BioSciences contact info: Phone number: 41******** Website: https://imagobio.com
Answer: Our scientific efforts are aimed at developing drugs that improve the management of proliferative diseases of the bone marrow. Our clinical focus is on acute myeloid leukemia, myelodysplastic syndrome, polycythemia vera, myelofibrosis and essential thrombocythemia. These diseases share several features. They are diseases caused by acquired mutations in blood stem cells. To varying degrees, these mutations drive excessive growth of bone marrow cells, as well as alter their function. For example, myelofibrosis can be viewed as a chronic inflammatory disorder in which inflammatory cytokines and growth factors cause bone marrow cells to alter the architecture of and ultimately destroy the bone marrow. Imago BioSciences has developed inhibitors of the enzyme lysine-specific demethylase 1 (LSD1). This enzyme plays a critical role in regulating the growth and development of bone marrow cells. Our first clinical inhibitor of LSD1, bomedemstat (or IMG-7289) is being studied in patients with acute myeloid leukemia, myelodysplastic syndrome, and myeloproliferative neoplasms including myelofibrosis. Future clinical studies are planned for other related diseases.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month